CATEGORIES

Pharmaceutics

LATEST

TRENDING

EDITORS CHOICE

Tech Marches On, While Humanity Drags Its Feet

I thought it would be fun to look back at some of my predictions for health tech from almost a decade ago in Forbes....

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Experts Say Covid-19 Vaccine Is Not Linked to Miscarriage or Infertility

Covid misinformation on social media circulate regarding a false link between Covid-19 vaccination and miscarriage.

Evrysdi™ Approved for Spinal Muscular Atrophy Home Treatment

The FDA has approved Evrysdi™ (risdiplam), the first at-home, orally administered treatment for spinal muscular atrophy in children and adults